Gabapentin Market Size & Share, by Dosage Form (Tablet, Capsule, Oral Solution); Type (Generic, Branded); Application (Neuropathic Pain, Epilepsy, Restless Legs, Syndrome); Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 5130
  • Published Date: Aug 06, 2023
  • Report Format: PDF, PPT

Companies Dominating the Gabapentin Market

top-features-companies
    • Sun Pharmaceutical Industries Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Ascend Laboratories
    • LLC Apotex Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Aurobindo Pharma.
    • Amneal Pharmaceuticals LLC.
    • Cipla USA, Inc.
    • BP Pharmaceuticals Laboratories Company
    • Assertio Holdings, Inc.
    • Arbor Pharmaceuticals, Inc.
    • Pfizer Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

· Pfizer Inc. announced the availability of its rheumatoid arthritis biosimilar, RUXIENCE, in July 2021.

· Pfizer Inc. disclosed in September 2021 that it would acquire Amplyx Pharmaceuticals, a privately held business that specializes in creating medications for life-threatening infections.


Author Credits:  Abhishek Verma, Hetal Singh


  • Report ID: 5130
  • Published Date: Aug 06, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The rising prevalence of neuropathic pain and the increasing availability of generic versions are some of the major factors anticipated to drive the growth of the gabapentin market.

The market is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Ascend Laboratories, LLC Apotex Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma., Amneal Pharmaceuticals LLC., Cipla USA, Inc., BP Pharmaceuticals Laboratories Company, Assertio Holdings, Inc., Arbor Pharmaceuticals, Inc., and others.

The hospital pharmacy segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying